Dr Mike Darsley

Head of Clinical Development

Mike is Prokarium’s Head of Clinical Development and brings over 25 years of experience in biopharmaceutial development from the USA, UK and Denmark. He was VP bacterial vaccine research at Acambis UK, Chief Development Officer at ACE Biosciences and TD Vaccines in Denmark and has provided independent product development consultancy for 3 years to pharma, biotech and academic clients. He has a BA in biochemistry and a D.Phil in molecular immunology from the University of Oxford and was a Fogarty International Postdoctoral Fellow at the National Cancer Institute, NIH, USA. Mike has been involved in the development of a number of vaccines against diarrhoeal diseases and continues to advise the Enteric Vaccine Initiative at PATH, a US NGO, on its ETEC vaccine program.